45
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Volume Flow Measurements in Arteriovenous Dialysis Access in Patients with and without Steal Syndrome

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction. Dialysis associated steal syndrome (DASS) constitutes a serious risk for patients undergoing vascular access operations. We aim to assess the measured volume flow using ultrasound in patients with clinically suspected steal syndrome and determine differences in flow among types of arteriovenous (AV) access. Methods. Patients with permanent hemodialysis access with and without ischemic steal underwent duplex ultrasound (US) exams for the assessment of volume flow and quantitative evidence of hemodynamic steal. Volume flow was measured in the proximal feeding artery. Results. 118 patients underwent US of which 82 (69.5%) had clinical evidence of steal. Women were more likely to develop steal compared to men (chi-squared test P < 0.04). Mean volume flow in patients with steal was 1542 mL/min compared to 1087 mL/min ( P < 0.002) in patients without evidence of steal. A significant difference in flow volumes in patients with and without steal was only seen in patients with a brachial-cephalic upper arm AV fistula (AVF) ( P < 0.002). When comparing different types of access with steal, brachial-cephalic upper arm AVFs had higher volume flows than the upper extremity AV graft (AVG) group ( P = 0.04). Conclusion. In patients with DASS, women were more likely to develop steal syndrome. Significantly higher volume flows were seen with brachial-cephalic upper arm AVF in patients with steal compared to those without. A physiologic basis of this US finding may be present, which warrants further study into the dynamics of flow and its relationship to the underlying peripheral arterial pathology in the development of ischemic steal.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: not found
          • Article: not found

          2005 Annual Report: ESRD Clinical Performance Measures Project.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Upper extremity ischemia and hemodialysis vascular access.

            Digital ischemia in dialysis patients due to arteriovenous fistulas (AVF) is a rare condition, occurring in 4% of patients. The etiology is different from lower limb ischemia. Blood shunting through the AVF may cause stealing of blood and hypoperfusion in distal tissues, leading to pain, discolorisation and ulcers. High-flow AVFs have greater risk on ischemia than normal flow AVFs, however combined with peripheral arteriosclerotic disease the latter may also leads to ischemia. A non-invasive and angiographic diagnosis is of importance to determine treatment options. Augmentation of arterial inflow by interventional techniques and/or AVF bloodflow-reducing surgical procedures may eliminate pain and heal ulcers. The best results are obtained by bypassing the arteriovenous anastomotic site and interruption of steal phenomenon by ligation of the artery distal to the AV anastomosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Predictive measures of vascular access thrombosis: a prospective study.

              Malfunction of permanent vascular accesses remains a cause of frequent and costly morbidity in patients receiving chronic hemodialysis (CHD). Several recommendations for routine monitoring of these permanent vascular accesses for incipient failure have been proposed. In this study, multiple indicators of incipient vascular access dysfunction, including "venous" and "arterial" pressures at serial blood flows (200 ml/min, 300 ml/min, and 400 ml/min), percent urea recirculation, Doppler ultrasound, and access blood flow by ultrasound dilution technique were simultaneously evaluated in a total of 220 vascular accesses in 170 chronic hemodialysis patients in two separate study periods (6 months apart). The rate of thrombosis was determined within the subsequent 12 weeks of each study period to assess the short-term predictive power of access thrombosis. During the period of follow-up, there were 34 thrombotic events in 172 polytetrafluoroethylene (PTFE) grafts and only one thrombotic event in 48 arterio-venous fistulas (AVF). Therefore, the statistical analysis was limited to the PTFE grafts. When grafts with thromboses were compared to those without thrombosis by univariate analysis, access blood flow measured either by ultrasound dilution technique (875 +/- 426 ml/min with thrombosis vs. 1193 +/- 677 ml/min without thrombosis, P = 0.001) or by Doppler ultrasound (762 +/- 420 ml/min with thrombosis vs. 1171 +/- 657 ml/min without thrombosis, P = 0.001) were significantly different in the two groups. There was good correlation (r = 0.79, P = 0.0001) between the blood flows determined by both techniques. The grade of stenosis determined by ultrasound was also a statistically significant predictor (P = 0.02). "Venous" and "arterial" pressures were numerically similar and were not statistically different between the accesses that did and those that did not thrombose. When multivariate analysis was used, there was a significantly increased risk of thrombosis only with decreasing access blood flow determined by ultrasound dilution techniques after adjusting for other confounding variables. When the average blood flow of all grafts (1134 ml/min) is considered as the reference access blood flow (relative risk of 1.0), the relative risk of a PTFE thrombotic event within the subsequent 12 weeks was 1.23 at a blood flow 950 ml/min, 1.67 at a blood flow of 650 ml/min and to 2.39 at a blood flow of 300 ml/min. In summary, access blood flow measured by either Dilution or Doppler is a reliable indicator of subsequent short-term thrombosis risk. Other proposed methods of evaluating access dysfunction were not useful in our patients. If simple to use, cost-effective devices to measure dialysis access blood flow become readily available, the measurement of access blood flow will likely become the method of choice for screening of PTFE vascular access dysfunction in hemodialysis patients.
                Bookmark

                Author and article information

                Journal
                Int J Vasc Med
                Int J Vasc Med
                IJVM
                International Journal of Vascular Medicine
                Hindawi Publishing Corporation
                2090-2824
                2090-2832
                2013
                27 August 2013
                : 2013
                : 328601
                Affiliations
                1Department of Cardiovascular Surgery, The Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, 6550 Fannin Street, Suite 1401 Houston, TX 77030, USA
                2Lebanese American University and University Medical Center Rizk Hospital, Beirut, Lebanon
                Author notes
                *Joseph J. Naoum: jjnaoum@ 123456tmhs.org

                Academic Editor: Mark Morasch

                Article
                10.1155/2013/328601
                3771444
                24066232
                e51879d9-dfcf-4594-a70e-d2e86d3eb524
                Copyright © 2013 Charudatta S. Bavare et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 22 May 2013
                : 25 July 2013
                : 28 July 2013
                Categories
                Clinical Study

                Cardiovascular Medicine
                Cardiovascular Medicine

                Comments

                Comment on this article